Back

Clinical experience of transapical off-pump mitral valve repair with NeoChord implantation

1 September 2024 (15:00 - 15:40)
Organised by: Logo
Congress Presentation Part of: Valvular heart disease: from risk stratification to intervention Valvular Heart Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Argyro Kalompatsou

Hippokration General Hospital, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
Mortality based right ventricle functional echocardiographic cutoffs in patients with compared to without tricuspid regurgitation
Doctor L. Zornitzki (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
Changes in mitral and tricuspid valve morphology after surgical repair of pectus excavatum
Doctor A. Goda (Nishinomiya, JP)
Abstract Slides Video
Presentation thumbnail
Predictive factors for recurrent tricuspid regurgitation after tricuspid annuloplasty: 3D echocardiography study
Mr D. Verikas (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
Tricuspid regurgitation in rheumatic heart valve disease. New insights from 3D transthoracic echocardiography
Doctor P. Mahia (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Predictors of heart failure hospitalization after surgery in patients with primary mitral regurgitation: the relevance of left atrial coupling index
Doctor P. O'Neill Gonzalez (Hermosillo Sonora, MX)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular heart disease: from risk stratification to intervention

The Event

Event poster

ESC Congress 2024

1 September 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Can elderly patients with severe mitral regurgitation be ideal candidates for MitraClip?
thumbnail
Congress Presentation
Single operator experience in combined m- teer and t- teer with a single TriClip steerable guide catheter
thumbnail
Congress Presentation
MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources